# Studying Tissue and Blood Samples From Patients With Acute Myeloid Leukemia

> **NCT00900224** · — · UNKNOWN · sponsor: **Alliance for Clinical Trials in Oncology** · enrollment: 529 (actual)

## Conditions studied

- Leukemia

## Interventions

- **GENETIC:** DNA analysis
- **GENETIC:** DNA methylation analysis
- **GENETIC:** gene expression analysis
- **GENETIC:** mutation analysis
- **GENETIC:** polymerase chain reaction
- **GENETIC:** reverse transcriptase-polymerase chain reaction
- **OTHER:** high performance liquid chromatography
- **OTHER:** laboratory biomarker analysis

## Key facts

- **NCT ID:** NCT00900224
- **Lead sponsor:** Alliance for Clinical Trials in Oncology
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-06
- **Primary completion:** 2015-12
- **Final completion:** —
- **Target enrollment:** 529 (ACTUAL)
- **Last updated:** 2023-08-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00900224

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00900224, "Studying Tissue and Blood Samples From Patients With Acute Myeloid Leukemia". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT00900224. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*